Get started
Live feed
PRReleasevia Quantisnow
Creative Medical Technology Holdings Inc. logo

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for CELZ

Across the 16 sessions after earlier CELZ headlines, the stock closed higher 8 times and lower 8 times, with a median move of 11.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

CELZ close-to-close change in the session after earlier headlines
SessionEarlier headlineCELZSPY
Sep 17, 2026Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing+6.8%+1.1%
Aug 20, 2026Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning+14.3%-0.8%
Aug 6, 2026Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms+71.9%-0.2%
Jul 1, 2026Creative Medical Technology Holdings Issues Mid-Year Update-12.4%-0.1%
Jun 30, 2026Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds+79.0%+0.8%
Jun 22, 2026Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain-13.5%-0.3%
Quantisnow market dataNASDAQ
Creative Medical Technology Holdings Inc. logo
CELZ
Creative Medical Technology Holdings Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for CELZ

Follow CELZ and get a push notification the moment its next story breaks.

Full CELZ profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELZ (Creative Medical Technology Holdings Inc.) and more on Quantisnow.